Clinical Trial

Evaluation of the EF192B Protection Versus No Treatment

Study acronym: Spray B
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2024 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study was designed with the objective of evaluating the protection potential provided by the experimental product EF192B by evaluating its barrier formation capacity. Once its ability to form a barrier is confirmed, EF192B ability to protect against small skin injuries, such as small cuts, bruises, blisters and cracks is confirmed. The barrier formation also guarantees protection against the formation of calluses.
Trial Details
NCT Number NCT06752460
Lead Sponsor Eurofarma Laboratorios S.A.
Conditions Skin Lesions, Skin Care
Enrollment 72 participants
Start Date 2025-08-31
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-30